BioAsia To Be Held From February 17 To 19, 2020 At HICC, Hyderabad
Mumbai, 2 Jan 2020:
With the theme - Today For Tomorrow - BioAsia 2020, will be held from February 17 to 19, 2020 at HICC, Hyderabad. The event will have participation from more than 50 countries and more than 70 speakers. It will also have participation of more than 800 companies and more than 1,800 visitors are expected. The event is organised by Government of Telangana.
The event will explore the capabilities that Life sciences companies should invest in today to thrive and create value tomorrow. Currently newer technologies, and ubiquity of data and analytics is continuing to blur the traditional boundaries between therapeutics, medical technologies, consumer devices and information technology (IT). This rapidly evolving market is putting pressure on the life sciences companies to change their business models and personalize their products and services. Hence, at BioAsia 2020, these companies will deliberate on how they should be preparing themselves for the future.
BioAsia is an event focusing on biotechnology and bio industries all across the world. Biotechnology is considered one among the most emerging industries today. The event aims to enhance, encourage and enrich latest innovations, technologies and discoveries in the field of biotechnology. The event brings together the pharmaceutical industries and global biotechnology industries. The event aims at conducting seminars and sessions to enable industrialists get in contact with latest inventors displaying potentially successful devices and technologies that would help flourish the biotechnology industry worldwide. This is a must attend event for all pharma companies and biotechnology, R&D departments all around the globe to network and enhance their standards.
BioAsia is born with a vision to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the biotechnology industry by offering a vibrant global platform for convergence of the key stakeholders - biotech & biopharma companies, research institutions, academia, investors, service providers, policy makers, regulators and analysts.
BioAsia is focused in its efforts - to drive the growth of the industry by enabling an effective environment for fostering collaborations, JV’s M&A’s; ensure knowledge and experience sharing by global industry players to benefit all stakeholders; promote innovations and initiatives through appropriate awards and recognitions; play a pivotal role in advocating issues to the policy makers and chartering the road-map of biotechnology.
BioAsia is a dynamic platform for companies -to exhibit, launch and showcase their unique strengths, products and services. BioAsia is playing the role of a key catalyst in mobilizing all elements that are required to drive the growth of the emerging industry of biotechnology as well as optimize the immense business potential of biotech. On a larger level, BioAsia is working to drive a global transformation from the treatment of illness to wellness. Pharmabiz